oncolytic herpes simplex virus (oHSV)-Gluc for cancer screening

therapoid
  • New development of oHSV-Gluc biotechnology
    Sponsored by Open Therapeutics™ on 2022-11-29 17:00 UTC
    Open for proposal submissions from 2022-12-31 17:01 UTC and voting against this grant starts from 2023-02-01 01:00 UTC